Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis.
1 other identifier
observational
400
0 countries
N/A
Brief Summary
Assessment of the outcome of patients not concluded fir cystic fibrosis, either symptomatic patients or asymptomatic children detected by newborn screening for cystic fibrosis. The aim is to identify patients potentially at risk of progressing to the clinical spectrum of cystic fibrosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2026
ExpectedMarch 12, 2024
March 1, 2024
2 years
March 2, 2024
March 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
lung Imaging
abnormal lung Imaging score, assessing the area of the lung with bronchiectasis, bronchial wall thickening, mucus plug and air trapping
within 3 months after visit
Secondary Outcomes (2)
lung infection
within 2 weeks after visit
pancreatic function
within 2 weeks after visit
Study Arms (1)
patients with unconcluded diagnosis for cystic fibrosis
1. symptomatic patientscarrying 2 variants of CFTR, including at least 1 non CF causing 2. patients not concluded at neonatal screening of Cystic Fibrosis
Interventions
collection of data of generated by "real world" follow up
Eligibility Criteria
children of adults not concluded for the diagnosis of Cystic fibrosis
You may qualify if:
- patients not concluded for the diagnosis of Cystic fibrosis either because of intermediate sweat test or because extensive genetic study has identified 2 vrainats at least 1 being not CF causing
You may not qualify if:
- patients carrying 2 CF causing variants of the CFTR gene
- patients carrying only 1 or no variants of CFTR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2024
First Posted
March 8, 2024
Study Start
May 1, 2024
Primary Completion
May 2, 2026
Study Completion (Estimated)
November 2, 2026
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share